Wolfgang Miesbach on Transforming Care for Women and Girls with Bleeding Disorders: Key Guidelines 2021–2024
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Advancing Care for Women and Girls with Bleeding Disorders
The clinical landscape has transformed significantly through evidence-based guidelines (2021-2024), finally addressing historical gaps in care for this mainly unrecognized population:
2021 ISTH Nomenclature Revolution
Eliminated outdated ‘carrier’ terminology
Established 5 evidence-based categories from severe to asymptomatic women and girls with bleeding disorders
Improved diagnostic accuracy and research uniformity
2021 ASH/ISTH/NHF/WFH VWD Guidelines
Prioritized hormonal therapy and tranexamic acid over desmopressin for heavy menstrual bleeding
Set clear diagnostic thresholds: <0.30 IU/mL (regardless of bleeding) and <0.50 IU/mL (with bleeding)
2021 European Principles of Care
EAHAD and EHC established 10 comprehensive care principles
Promoted systematic screening across European centers
2024 NBDF MASAC Guidelines
Document 286: Most comprehensive update yet
Mandated iron deficiency screening even with normal hemoglobin
Addressed historical underdiagnosis gaps
Persistent Challenges:
Despite progress, women and girls with bleeding disorders remain systematically excluded from clinical trials, creating dangerous knowledge gaps that impact:
Diagnostic delays
Higher anemia & transfusion rates
Unnecessary hysterectomies
25% report severe reproductive decision impact
The path forward requires collaborative research and gender-specific treatment studies to truly close these healthcare disparities.”
Stay informed with Hemostasis Today.
-
Aug 16, 2026, 13:21Francois Roubille: New ESC Consensus on Inflammation in Coronary Syndromes
-
Aug 16, 2026, 13:05Neil Morgan: Submit Your Abstract for BSHT 2027
-
Aug 16, 2026, 12:50Heba Youssef: Can Cefoperazone Cause Coagulopathy?
-
Aug 16, 2026, 12:35Mohammad Alkhalil: Stroke Remains a Dreaded Complication in TAVI
-
Aug 16, 2026, 12:16Jeff Schaffnit: The Power of Community in Rare Blood Disorders
-
Aug 16, 2026, 12:03Fawaz AlOtaibi: Can AI Replace Contrast CTA for Vascular Screening?
-
Aug 16, 2026, 10:31Erhabor Osaro: Critical Issues to Consider During the Clinical Blood Transfusion Process
-
Aug 16, 2026, 10:14Juan Manuel Cisneros Carrasco: The Architects Behind the Blood Donation System
-
Aug 16, 2026, 10:06Honoring the Life and Legacy of Dr. Reed Pyeritz – GADA Canada